Telememory
Techstars '21Kansas City, US · 1 known investors
Find your way into Telememory
Sign up to find every way you can get introduced to Telememory
- Your email: who you already know at Telememory, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Telememory team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Kansas City telehealth startup using AI-based digital reminiscence technology to support seniors with cognitive decline.
Also known as MoodSpark · TeleMemory · Telememory Holding Corp. · Telememory, LLC
Investors · 1
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Company profile
researched Sep 2026Telememory (Telememory, LLC; later Telememory Holding Corp.) is a Kansas City, Kansas-based telehealth company that develops AI-based digital reminiscence technology intended to connect families with their memories and to track emotional responses, with the stated aim of improving happiness and health among people experiencing loneliness, isolation and cognitive decline. Its initial product, Reminisce+, collects information about a patient's life through a digital biography process, curates personalized content such as music, art, video and images intended to invoke long-term memory recall, lets families stream and share that content through narrowcasting and telepresence tools such as Apple FaceTime, analyzes emotional and biometric responses to gauge recall, and issues content recommendations and alerts based on those responses. The company has described the underlying technology as patent-pending.
The company later operated under the MoodSpark brand, described as a digital companion and robotic assistive technology for seniors that uses AI to detect signals of agitation, sadness or stress, performs automated check-ins, sends alerts and notifications to family and friends, delivers behavioral health intervention via digital reminiscence therapy, and shares engagement and response data with families and caregivers. MoodSpark's stated focus markets are the aging U.S. veteran population and the broader senior care market. Telememory positions its products as non-pharmacological interventions and states that they allow caregivers to scale therapeutic approaches across more patients without increasing the cost of care.
Founding story
Founder and CEO Eliot Arnold has said he started Telememory after his father was diagnosed with dementia, when he found no technology purpose-built to keep his father connected to his interests — art, music, bridge, family and friends — and sought non-pharmacological approaches to improve his father's mood, slow cognitive decline and keep him engaged.
Business model
The company sells software-driven reminiscence and companion-care technology for use by memory care providers, senior care organizations and families, positioning the products as a way for caregivers to extend therapeutic interventions across more patients without added cost of care.
Traction
Telememory ran a month-long alpha program with Delmar Gardens Enterprises, an operator serving over 4,000 seniors across six states, beginning November 2020, and was selected for the 2021 Techstars Kansas City Accelerator cohort.
Latest developments
In May 2022, Telememory Holding Corp., maker of MoodSpark, completed the purchase of Dthera Sciences (OTCPK:DTHR), bringing an intellectual property portfolio including an FDA Breakthrough Device designation, several patents, a technology platform and clinical pilot research under the MoodSpark banner.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
The company operates in the emerging digital therapeutics and robotic assistive technology segments for geriatric CNS conditions. Management stated that the Dthera Sciences acquisition provided market validation, broadened its IP portfolio and was intended to establish the company as a leader in social assistive technology.
The company states its patent-pending approach is unique in combining remote re-living of experiences with friends and family with measurement of memory recollection and overall engagement, and in offering a non-pharmacological intervention for mood, anxiety and isolation.
Technology
Telememory's platform captures a patient's life history through a digital biography process and curates personalized multimedia content designed to stimulate long-term memory recall. Content is delivered remotely through narrowcasting and telepresence technology, including Apple FaceTime. The system analyzes emotional and biometric responses to measure recall and engagement, and generates content recommendations and alerts. The MoodSpark digital companion applies AI to detect agitation, sadness or stress, conducts automated check-ins, and delivers digital reminiscence therapy. Through the Dthera Sciences acquisition the company added patents, a technology platform, clinical pilot research and an FDA Breakthrough Device designation for treating behavioral symptoms of Alzheimer's disease.
Go-to-market
Early commercialization proceeded through pilot and alpha programs with senior care operators such as Delmar Gardens Enterprises, whose findings were to be incorporated into beta features, supported by participation in the Techstars Kansas City accelerator.
Memory care and senior living operators, caregivers and families of patients with Alzheimer's, dementia and other neurodegenerative conditions; MoodSpark additionally targets aging U.S. veterans and the broader senior care market.
Geography
Headquartered in Kansas City, Kansas, with an early pilot deployment at Chesterfield, Missouri-based Delmar Gardens Enterprises; acquired San Diego-based Dthera Sciences.
History
Telememory, LLC announced an alpha testing program with Delmar Gardens Enterprises in November 2020, deploying its Reminisce+ technology in memory care settings. In June 2021 the company was named to the Techstars Kansas City Accelerator 2021 cohort, a three-month program focused on mentoring and investor readiness alongside nine other startups; the company had earlier pitched at 1 Million Cups – Kansas City in February 2021. By May 2022 the business operated as Telememory Holding Corp. doing business as MoodSpark and announced the acquisition of San Diego-based Dthera Sciences.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Timeline · 3
launches, deals, and filingsTelememory Holding Corp., dba MoodSpark, completed the acquisition of San Diego-based digital therapeutics company Dthera Sciences (OTCPK:DTHR), adding patents, a technology platform, clinical pilot research and an FDA Breakthrough Device designation.
TeleMemory joined nine other startups in the three-month Techstars Kansas City Accelerator program focused on mentoring and investor readiness.
Telememory announced a month-long alpha testing program deploying its Reminisce+ digital reminiscence technology with memory care patients at Delmar Gardens Enterprises, a Chesterfield, Missouri-based senior care operator.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 8
primary sources listed
- TELEMEMORY · GitHubgithub.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Telememory do?
- Kansas City telehealth startup using AI-based digital reminiscence technology to support seniors with cognitive decline.
- Who are Telememory's investors?
- Telememory's investors include Techstars.
- Where is Telememory headquartered?
- Telememory is headquartered in Kansas City, US.

